Skin Cancer Treatment
Here, at the UCLA Radiation Oncology Division of Brachytherapy, we are committed to making your cancer treatment a comfortable and successful experience. We offer individualized High Dose Rate (HDR) Brachytherapy for skin cancer, which minimizes the amount of radiation and side effects on nearby healthy tissues.
What is Skin HDR Brachytherapy?
Skin HDR Brachytherapy is a radiotherapy technique which is performed for certain types of basal cell or squamous cell skin cancers. It provides an effective alternative treatment with minimal side effects for selected patients and those who cannot be treated surgically.
Benefit of HDR Brachytherapy on skin cancer
- May avoid the need for reconstructive surgery.
- Reduction in normal tissue injury means more rapid and complete functional recovery.
- Shorter overall treatment times than external beam radiation therapy and each fraction (session) of treatment can be completed in a matter of minutes.
Figure 1: Patient with a squamous cell carcinoma cancer of the lower right leg treated with a HDR customize applicator.
Figure 2: Patient with a squamous cell carcinoma cancer of the lower right leg treated with a HDR customize applicator.
Figure 3: Patient with basal cell carcinoma of the right nose treated with a Leipzig applicator.
Figure 4: Patient with basal cell carcinoma of the right nose treated with a Leipzig applicator.
Our Brachytherapy Experts:
Albert Chang, MD, PhDAssociate Professor and Vice Chair, Surgical ServicesDirector of Brachytherapy Services
Dr. Albert Chang, Associate Professor, is the Vice Chair of Surgical Services and Brachytherapy Service Chief for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center. Dr. Chang received his Ph.D. in Molecular Medicine and M.D. degrees from the Boston University School of Medicine. He completed his residency at the Washington University School of Medicine, and then joined the faculty at the University of California, San Francisco as an Assistant Professor. More »
David Jeffrey Demanes, MD, FACRO
Dr. Jeffrey Demanes received his bachelor of arts degree from UC Berkeley and his medical degree from the David Geffen School of Medicine at UCLA. He completed residencies in internal medicine and radiation oncology at UCLA and his medical oncology fellowship at UCSF. He is the past chairman and president of the American College of Radiation Oncology. Dr. Demanes specializes in brachytherapy, the surgical subspecialty of radiation oncology. He founded the California Endocurietherapy Center (CET) in 1981 and has performed more than 10,000 surgical radiation implants. More »